AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Owlet Launches Owlet360™ in the UK and Ireland, Bringing Data-Driven Reassurance to More Families
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
FDA Approves Renewal of Canalevia-CA1, Jaguar Healths Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
OneMedNet Reports Strong Momentum and Industry Excitement at RSNA
Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™
Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds
Veru to Report Fiscal Year 2025 Financial Results on December 17th
IceCures ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology